Vincent R. Anicetti, Chief Operating Officer at Coherus BioSciences, Inc. (CHRS), sold 2,488 shares at $17.45 ($43K) on 2021-02-17, disclosed to the SEC on 2021-02-19.
Scheduled sale ($43k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CHRS | SELL | 2020-12-21 | $44K | — | Filing → |
| CHRS | SELL | 2020-12-09 | $324K | — | Filing → |
| CHRS | SELL | 2020-12-07 | $3.7M | — | Filing → |